Terms: = Uterine cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
150 results:
1. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
2. Genomic profile of Chinese patients with endometrial carcinoma.
Li J; Li X; Quan C; Li X; Wan C; Wu X
BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
[TBL] [Abstract] [Full Text] [Related]
3. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis.
Brown M; Leon A; Kedzierska K; Moore C; Belnoue-Davis HL; Flach S; Lydon JP; DeMayo FJ; Lewis A; Bosse T; Tomlinson I; Church DN
EMBO Mol Med; 2023 Oct; 15(10):e17094. PubMed ID: 37589076
[TBL] [Abstract] [Full Text] [Related]
4. Alteration of tumor suppressors changes the endometrial tumor spectrum.
Mayo LD
EMBO Mol Med; 2023 Oct; 15(10):e18166. PubMed ID: 37587857
[TBL] [Abstract] [Full Text] [Related]
5. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
6. Expression and clinical significance of PD-1 in UCEC and its Impact on tumor.
Xing F; Yang Y; Zheng W
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):168-173. PubMed ID: 37571885
[TBL] [Abstract] [Full Text] [Related]
7. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
[TBL] [Abstract] [Full Text] [Related]
8. HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis.
Bruce SF; Wu S; Ribeiro JR; Farrell A; Oberley MJ; Winer I; Erickson BK; Klc T; Jones NL; Thaker PH; Powell MA
Gynecol Oncol; 2023 May; 172():98-105. PubMed ID: 37003074
[TBL] [Abstract] [Full Text] [Related]
9. pten mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
[TBL] [Abstract] [Full Text] [Related]
10. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The cancer Genome Atlas-like Prognostic Subgroups.
Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
[TBL] [Abstract] [Full Text] [Related]
12.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
13. The role of poly (ADP-ribose) glycohydrolase in phosphatase and tensin homolog deficiency endometrial cancer.
Sun Y; Shi Y; Liu H; Lv C; Zhang A
J Obstet Gynaecol Res; 2023 Apr; 49(4):1244-1254. PubMed ID: 36759425
[TBL] [Abstract] [Full Text] [Related]
14. A Novel Defined Pyroptosis-Related Gene Signature for Predicting the prognosis of Endometrial cancer.
Liu S; Zeng C; Lv H; Zhang Y; Xiong H; Tang H
Dis Markers; 2022; 2022():7570494. PubMed ID: 36601599
[TBL] [Abstract] [Full Text] [Related]
15. pten mutations as predictive marker for the high-grade endometrial cancer development in slovak women.
Gbelcová H; Gergely L; Šišovský V; Straka Ľ; Böhmer D; Pastoráková A; Sušienková K; Repiská V; Korbeľ M; Danihel Ľ; Priščáková P
Physiol Res; 2022 Dec; 71(Suppl 1):S125-S135. PubMed ID: 36592448
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.
van Bommel MHD; Pijnenborg JMA; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; Ligtenberg MJL; Eijkelenboom A; de Hullu JA; Reijnen C
Int J Gynecol Cancer; 2022 Dec; 32(12):1568-1575. PubMed ID: 36384753
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
18. Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
Gebrie A
PLoS One; 2022; 17(7):e0268480. PubMed ID: 35895593
[TBL] [Abstract] [Full Text] [Related]
19. Construction and validation of a prognostic model based on 11 lymph node metastasis-related genes for overall survival in endometrial cancer.
Wu H; Feng H; Miao X; Ma J; Liu C; Zhang L; Yang L
Cancer Med; 2022 Dec; 11(23):4641-4655. PubMed ID: 35778922
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate pten-deficient endometrial carcinoma.
Zhang X; Huang P; Wang L; Chen S; Basappa B; Zhu T; Lobie PE; Pandey V
Cell Death Dis; 2022 Jun; 13(6):558. PubMed ID: 35725817
[TBL] [Abstract] [Full Text] [Related]
[Next]
